Research blog
May 11, 2026 Research use only

DSIP Research Notes

Selected PubMed sources, evidence limits, and current BioPep USA catalog and documentation status for DSIP. Research use only.

Delta sleep-inducing peptide 2D compound structure
Research-use-only scope: This article organizes published sources and BioPep USA records. It does not provide preparation, dosing, injection, human-use, animal-use, therapeutic, diagnostic, cosmetic, or clinical guidance.

DSIP literature is older and largely experimental. The selected records cover transport and signaling observations in animal or isolated-system models.

Questions covered by the selected literature

  • How DSIP transport was studied at the blood-brain barrier
  • Which neurotransmitter systems were examined in older experiments
  • Why early experimental observations require cautious interpretation

Evidence limits

These are older experimental records, not current clinical evidence. BioPep USA does not currently publish an active DSIP product page.

A paper should be read according to its own model, methods, controls, and endpoints. Cell, animal, analytical, review, and human records are not interchangeable.

Selected PubMed sources

  1. Saturable mechanism for delta sleep-inducing peptide (DSIP) at the blood-brain barrier of the vascularly perfused guinea pig brain.. Peptides. 1989 Mar-Apr. PMID: 2547200.
  2. Delta sleep inducing peptide inhibits somatostatin release via a dopaminergic mechanism.. Neuroendocrinology. 1987 Jun. PMID: 2886936.
  3. Delta sleep-inducing peptide modulates the stimulation of rat pineal N-acetyltransferase activity by involving the alpha 1-adrenergic receptor.. J Neurochem. 1987 Apr. PMID: 3029331.

BioPep USA record

BioPep USA does not currently publish an active standalone DSIP product. The documentation page records that catalog status.

Last reviewed: July 20, 2026.